Fresenius FY24 Results
Financial Results
Q1/2025 – Coming soon!
We are pleased to inform you that Fresenius will announce its Q1/2025 results on May 7, 2025. The conference call will take place at 1:30 pm (CEST). Please find the dial-in details below.
Ahead of the Q1/2025 results, we are releasing the Fresenius Aide Memoire, which is based on publicly available information.
Please note that our quiet period will commence from April 24 and extend through May 6. We will be back on May 7 with all relevant documents to present our Q1/2025 financial results, business updates and more.
Q1/25 Results
WebcastDocuments
Q1/25 Aide Memoire (PDF)Selected Key Figures FY/2024
GROUP REVENUE 1
€ 21526 m
+ 8% 2
FY/23: €20,307 m
GROUP EBIT 1
€ 2489 m
+10% 3
FY/23: 2,266 m
NET INCOME 1, 4
€ 1461 m
+13% 3
FY/23: €1,300 m
EPS 1, 4
€ 2.59
+13% 3
FY/23: €2.31
1 Before special items
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation
4 Excluding Fresenius Medical Care
Revenue by business segment
| € in millions | FY/24 | FY/23 | Growth at actual rates | Growth at constant rates | Organic growth1 | Acquisitions/Divestitures | % of total revenue |
|---|---|---|---|---|---|---|---|
Fresenius Kabi | 8,414 | 8,009 | 5% | 9% | 10%1 | -1% | 39% |
Fresenius Helios | 12,739 | 11,952 | 7% | 6% | 6% | 0% | 59% |
Total | 21,526 | 20,307 | 6% | 7% | 8% | -1% | 100%2 |
-
1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
2 Remaining 2% Corporate/Other revenue
Before special items